Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 993-1004

  Punnonen, Juha ^a   Cocks, Benjamin G ^a   Carballido, José M ^a   Bennett, Bruce ^a   Peterson, David ^a   Aversa, Gregorio ^a   De Vries, Jan E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BINDING AFFINITY; CELL CULTURE; DNA DETERMINATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; B-LYMPHOCYTES; CELL MEMBRANE; CELLS, CULTURED; DNA PRIMERS; GLYCOPROTEINS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOGLOBULINS; INTERLEUKINS; KINETICS; L CELLS (CELL LINE); LYMPHOCYTE ACTIVATION; MICE; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SPLEEN; TRANSFECTION;

EID: 0030910358     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.993     Document Type: Article

References (53)

1. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
2. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
3. De Vries, J. E. and J. Punnonen. 1996. Interleukin-4 and interleukin-13. In Cytokine Regulation of Humoral Immunity: Basic and Clinical Aspects. C.M. Snapper, editor. John Wiley & Sons, Ltd., West Sussex, UK. 195-215.
4. Hirano, T., K. Yasukawa, H. Harada, T. Taga, Y. Watanabe, T. Matsuda, S. Kashiwamura, K. Nakajima, K. Koyama, A. Iwamatsu et al. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature (Lond.). 324:73-76.
5. Kimata, H., A. Yoshida, C. Ishioka, I. Lindley, and H. Mikawa. 1992. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J. Exp. Med. 176:1227-1231.
6. Rousset F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1890-1893.
7. Wakasugi, H., L. Rimsky, Y. Mahe, A. M. Kamel, D. Fradelizi, T. Tursz, and J. Bertoglio. 1987. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc. Natl. Acad. Sci. USA. 84:804-808.
8. Rieckmann, P., F. D'Alessandro, R. P. Nordan, A. S. Fauci, and J. H. Kehrl. 1991. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. J. Immunol. 146:3462-3468.
9. Burdin, N., C. Peronne, J. Banchereau, and F. Rousset. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 177:295-304.
10. Boussiotis, V.A., L.M. Nadler, J.L. Strominger, and A.E. Goldfeld. 1994. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc. Natl. Acad. Sci. USA. 91:7007-7011.
11. Estrov Z., R. Kurzrock, E. Pocsik, S. Pathak, H.M. Kantarjian, T.F. Zipf, D. Harris, M. Talpaz, and B.B. Aggarwal. 1993. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J. Exp. Med. 177:763-774.
12. Clark, E.A., and J.A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA. 83:4494-4498.
13. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lond.). 357:80-82.
14. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N.J. Chalupny, S. Braesch-Andersen, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory-activity. EMBO (Eur. Mol. Biol. Organ.) J. 11:4313-4321.
15. Cocks, B.G., R. de Waal Malefyt, J.P. Galizzi, J.E. De Vries, and G. Aversa. 1993. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 5:657-663.
16. Spriggs, M.K., R.J. Armitage, L. Strockbine, K.N. Clifford, B.M. Macduff, T.A. Sato, C.R. Maliszewski, and W.C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543-1550.
17. Clark, E.A., and J.A. Ledbetter. 1994. How B and T cells talk to each other. Nature (Lond.). 367:425-428.
18. Rickert, R.C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (Lond.). 376:352-355.
19. Kobata, T., S. Jacquot, K. Agematsu, S.F. Schlossman, and C. Morimoto. 1995. CD27-CD70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA. 92:11249-11253.
20. Aversa, G., J. Punnonen, and J.E. De Vries. 1993. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177:1575-1585.
21. Macchia, D., F. Almerigogna, P. Parronchi, A. Ravina, E. Maggi, and S. Romagnani. 1993. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature (Lond.). 363:464-466.
22. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R.S. Rosen, T. Chatila, S.M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
23. Di Santo, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. De Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:541-543.
24. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D. K. Simoneaux, B.C. Fanslow, J. Belmont, and M.K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259:990-993.
25. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, and M. Neubauer. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
26. Renshaw, B.R., W.C. Fanslow, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
27. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
28. Life, P., J.F. Gauchat, V. Schnuriger, S. Estoppey, G. Mazzei, A. Durandy, A. Fischer, and J.Y. Bonnefoy. 1994. T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand. J. Exp. Med. 180:1775-1784.
29. Cocks, B.G., C.-C.J. Chang, J.M. Carballido, H. Yssel, J.E. De Vries, and G. Aversa. 1995. A novel receptor involved in T-cell activation. Nature (Lond.). 376:260-263.
30. Davis, S. J., and P. A. van der Merwe. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17:177-187.
31. Mathew, P.A., B.A. Garni-Wagner, K. Land, A. Takashima, E. Stoneman, M. Bennett, and V. Kumar. 1993. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151:5328-5337.
32. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (Wash. DC). 251:70-72.
33. Balasubramanian, S., T. Chernov-Rogan, A.M. Davis, E. Whitehorn, E. Tate, M.P. Bell, G. Zurawski, and R.W. Barrett. 1995. Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits. Int. Immunol. 7:1839-1849.
34. Punnonen, J., G. Aversa, B.G. Cocks, A.N.J. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J.E. De Vries. 1993. Interleukin 13 induces Interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:3730-3734.
35. thi Bich-Thuy, L., and A.S. Fauci. 1985. Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro. Eur. J. Immunol. 15:1075-1079.
36. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature (Lond.). 372:425-432.
37. Wong, M.H., and M.T. Filbin. 1994. The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain. J. Cell Biol. 126:1089-1097.
38. Proust, J.J., F.J. Chrest, M.A. Buchholz, and A.A. Nordin. 1985. G0 B cells activated by anti-m acquire the ability to proliferate in response to B cell-activating factors independently from entry into G1 phase. J. Immunol. 135:3056-3061.
39. Meuer, S.C., R.E. Hussey, M. Fabbi, D. Fox, O. Acuto, K.A. Fitzgerald, J.C. Hodgdon, J.P. Protentis, S.F. Schlossman, and E.L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell. 36:897-906.
40. Siliciano, R.F., J.C. Pratt, R.E. Schmidt, J. Ritz, and E.L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature (Lond.). 317:428-130.
41. Selvaraj, P., M.L. Plunkett, M. Dustin, M.E. Sanders, S. Shaw, and T.A. Springer. 1987. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature (Lond.). 326:400-403.
42. Koyasu, S., T. Lawton, D. Novick, M.A. Recny, R.F. Siliciano, B.P. Wallner, and E.L. Reinherz. 1990. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA. 87:2603-2607.
43. Muraguchi, A., N. Kawamura, A. Hori, Y. Horii, Y. Ichigi, M. Kimoto, and T. Kishimoto. 1992. Expression of the CD2 molecule on human B lymphoid progenitors. Int. Immunol. 8:841-849.
44. + human thymic B cell subset. J. Immunol. 151: 100-110.
45. Sen, J., P. Bossu, S.J. Burakoff, and A.K. Abbas. 1992. T cell surface molecules regulating noncognate B lymphocyte activation: role of CD2 and LFA-1. J. Immunol. 148:1037-1042.
46. Diaz-Sanchez, D., S. Chegini, K. Zhang, and A. Saxon. 1994. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. J. Immunol. 153:10-20.
47. Songyang, Z., S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Ratnofsky, R.J. Lechleider et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:767-778.
48. Muraguchi, A., J.H. Kehrl, D.L. Longo, D.J. Volkman, K.A. Smith, and A.S. Fauci. 1985. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J. Exp. Med. 161:181-197.
49. Snapper, C.M., and W.E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (Wash. DC). 236:944-947.
50. Horwitz, D.A., H. Wang, and J.D. Gray. 1994. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA. Lupus. 3:423-128.
51. Schulze-Koops, H., P.E. Lipsky, A.F. Kavanaugh, and L.S. Davis. 1995. Elevated Th1-or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. J. Immunol. 155:5029-5037.
52. Mills, J.A. 1994. Systemic lupus erythematosus. N. Engl. J. Med. 330:1871-1879.
53. Simon, A.K., E. Seipelt, and J. Sieper. 1994. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 91:8562-8566.